Differentially‐regulated miRNAs in COVID‐19: A systematic review
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is responsible for
coronavirus disease of 2019 (COVID‐19) that infected more than 760 million people …
coronavirus disease of 2019 (COVID‐19) that infected more than 760 million people …
[HTML][HTML] COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments
I Gilyazova, Y Timasheva, A Karunas… - Non-coding RNA …, 2023 - Elsevier
The novel coronavirus infection (COVID-19) causes a severe acute illness with the
development of respiratory distress syndrome in some cases. COVID-19 is a global problem …
development of respiratory distress syndrome in some cases. COVID-19 is a global problem …
SARS-CoV2 infection induce miR-155 expression and skewed Th17/Treg balance by changing SOCS1 level: A clinical study
Background One of the regulators in severe acute respiratory syndrome coronavirus2
(SARS-CoV2) infection is miRNAs. In COVID-19 patients, immunological responses to …
(SARS-CoV2) infection is miRNAs. In COVID-19 patients, immunological responses to …
Bioinformatics and system biology approach to identify potential common pathogenesis for COVID-19 infection and sarcopenia
J Zhong, H Yuan, J Yang, Y Du, Z Li, X Liu… - Frontiers in …, 2024 - frontiersin.org
Sarcopenia is a condition characterized by age-related loss of muscle mass and strength.
Increasing evidence suggests that patients with sarcopenia have higher rates of coronavirus …
Increasing evidence suggests that patients with sarcopenia have higher rates of coronavirus …
The potential of circulating microRNAs as novel diagnostic biomarkers of COVID-19: a systematic review and meta-analysis
Introduction The COVID-19 pandemic has caused an unprecedented health threat globally,
necessitating innovative and efficient diagnostic approaches for timely identification of …
necessitating innovative and efficient diagnostic approaches for timely identification of …